Searched for
PHARMACEUTICAL EXPORTS
Share of services in exports rises to 48.8% in FY26India's services exports have seen significant growth. The services sector now accounts for nearly half of the country's total exports. Thi...- P&G India flags pressure on consumer demand, input costsProcter and Gamble India sees rising costs and softening urban demand, with company executives saying inflation will impact consumer spendi...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Durable US-Iran peace deal to provide predictable environment for trade: CRFA US-Iran peace deal promises greater regional stability. This will benefit Indian exporters with reduced costs for shipping, insurance, an...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- Leapfrog Engineering Services IPO to open on Wed at Rs 21-23 per shareLeapfrog Engineering Services Ltd has set its IPO price band at Rs 21-23 per share, opening for subscription on June 17, 2026. The Rs 88.51...
- Why a Rs 72,000 crore fund manager refuses to chase defence rally nowICICI Prudential's Mittul Kalawadia advises caution on current market valuations. He notes that future growth is already factored into stoc...
- US-Iran peace deal may help boost India's exports, stabilise rupeeA peace deal between the US and Iran is set to reopen the Strait of Hormuz. This agreement is anticipated to significantly boost India's ex...
- Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gearsIndia's electronics sector is poised for significant growth, potentially becoming a manufacturing and export powerhouse. Free Trade Agreeme...
- India's FTAs set stage for $1 trillion export target: ReportIndia's new generation of Free Trade Agreements can act as a catalyst for manufacturing expansion, private capex revival and supply-chain i...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- India-Oman trade pact to open huge export opportunities for labour-intensive sectors: ExpertsIndia and Oman's new trade pact unlocks significant export potential for sectors like textiles, gems, and marine products. This agreement a...
- Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Packaging firms remain upbeat on FY27 growth despite raw material volatility amid West Asia crisisDespite these disruptions, companies like EPL Ltd, Uflex, and TCPL Packaging remain optimistic about FY27 growth, driven by strong domestic...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- India can increase seafood exports to $30 billion in five years: Piyush GoyalIndia targets $30 billion in seafood exports within five years. This ambitious goal involves increasing production and quality. The nation ...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
Load More
